Aeglea Biotherapeutics

AGLE

6.90

-0.06

-0.9%

Stock Price
Open: 0.00
Prev. Close: 6.96
Low/Hi: 0.00 - 0.00
52-Week: 3.66 - 10.34
Volumes
Equity: 93
90-Day Avg: 77,112
Volatility
Today: NaN
20-Day: 91.0
52-Week: 104.7
Fundamental
Div. Yield: 0.0%
Earnings: 5-Jul (Est.)
P/E Ratio:
Market Cap: 93.6 M
Stock Type: Common | Sector: N/A | Industry: N/A

AGLE Balance Sheet

Numbers are in thousands. Data provided by Sage Data Service.
Period Ending 31-Dec-2016 30-Sep-2016 30-Jun-2016 31-Mar-2016
Cash and Cash Equivalents 47,748 49,544 70,628 24,016
Short Term Investments 15,754 18,491 2,947 4,970
Investments - - - -
Accounts Receivable 1,215 1,571 1,625 1,618
Inventory 0 0 0 0
Loans - - - -
Prepaid Expenses 1,707 2,073 1,551 1,325
Net Property Plant and Equipment 599 342 377 321
Other Current Assets 0 0 155 3,275
Current Assets 66,424 71,679 76,906 35,204
Goodwill and Intangibles 0 0 0 0
Long Term Investments 0 0 0 0
Other Assets - - - -
Long Term Receivables 0 0 0 0
Total Assets 67,063 72,061 77,301 35,543
Short Term Debt 0 0 0 0
Other Non-Current Assets 40 40 18 18
Accounts Payable 168 523 348 509
Accrued Liabilities and Other Payables 3,726 3,133 3,013 3,311
Long Term Debt 0 0 0 0
Other Liabilities - - - -
Current Portion of Long Term Debt 0 0 0 0
Total Liabilities 4,097 3,863 3,377 3,842
Other Current Liabilities 71 181 0 0
Accumulated Other Comprehensive Income -4 3 1 3
Preferred Stock 0 0 0 58,311
Current Liabilities 3,965 3,837 3,361 3,820
Common Stock 1 1 1 0
Other Non-Current Liabilities 132 26 16 22
Additional Paid-In Capital 108,246 107,988 107,478 1,513
Treasury Stock 0 0 0 0
Other Equity 0 0 0 0
Retained Earnings -45,277 -39,794 -33,556 -28,126
Total Equity 62,966 68,198 73,924 31,701
Period Ending 31-Dec-2016 31-Dec-2015 31-Dec-2014
Cash and Cash Equivalents 47,748 29,294 2,616
Short Term Investments 15,754 3,768 0
Investments - - -
Accounts Receivable 1,215 1,697 0
Inventory 0 0 0
Loans - - -
Prepaid Expenses 1,707 912 74
Net Property Plant and Equipment 599 348 162
Other Current Assets 0 2,615 40
Current Assets 66,424 38,286 2,730
Goodwill and Intangibles 0 0 0
Long Term Investments 0 0 0
Other Assets - - -
Long Term Receivables 0 0 0
Total Assets 67,063 38,654 2,930
Short Term Debt 0 0 0
Other Non-Current Assets 40 20 38
Accounts Payable 168 176 345
Accrued Liabilities and Other Payables 3,726 2,347 713
Long Term Debt 0 0 0
Other Liabilities - - -
Current Portion of Long Term Debt 0 0 0
Total Liabilities 4,097 2,550 1,058
Other Current Liabilities 71 0 0
Accumulated Other Comprehensive Income -4 -1 0
Preferred Stock 0 58,311 13,345
Current Liabilities 3,965 2,523 1,058
Common Stock 1 0 811
Other Non-Current Liabilities 132 27 0
Additional Paid-In Capital 108,246 1,373 0
Treasury Stock 0 0 0
Other Equity 0 0 0
Retained Earnings -45,277 -23,579 -12,284
Total Equity 62,966 36,104 1,872